See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
BRICS
Social Media
Artificial Intelligence
Floods
Amazon
Donald Trump
Tennis
South America
Natural Disasters
European Union
Instagram
Drones
Published • loading... • Updated

Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug

Summary by CNBC
Cigna accused Bristol Myers Squibb of violating antitrust law by keeping generic versions of its blood cancer drug Pomalyst off the market to retain a monopoly.

1 Articles

All
Left
Center
1
Right
CNBCCNBC
Center

Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug

Cigna accused Bristol Myers Squibb of violating antitrust law by keeping generic versions of its blood cancer drug Pomalyst off the market to retain a monopoly.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Tuesday, June 24, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cigna icon

Cigna

Bristol, United States icon

Bristol, United States

News
For You
SearchBlindspotLocal